Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061766) titled 'Pediatric Enteral Assessment of Real-world Long-term outcomes with Teduglutide for Short Bowel Syndrome in Japan' on June 2.
Study Type:
Observational
Primary Sponsor:
Institute - Takeda Pharmaceutical Company Limited
Condition:
Condition - Short Bowel Syndrome
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to retrospectively collect and analyze actual clinical experience with teduglutide in patients with SBS weighing less than 10 kg in Japan to clarify their background characteristics and clinical course. Specifically, the objective...